KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:KPC Pharmaceuticals Inc (600422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8105
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs such as xuesaitong Injection, xuesaitong soft capsules, xuesaitong freeze-dried powder for injection, gastrodin capsules, acetagastrodin tablets, gastrodin tablets, colchicines tablet, fibrauretine tablets and injection, and breviscapine tablets, among others. KPC conducts research and development to develop new drugs. The company’s drugs are used for central nervous system disorder, cardiovascular disorders and malaria. It offers its products under the brands Luotai, Tianxuanqing, Artemedine, Artem and Arco. KPC is headquartered in Kunming, China.

KPC Pharmaceuticals Inc (600422) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Rani Therapeutics Raises Funds in Financing 12
Partnerships 14
KPC Pharma to Form Joint Venture 14
Kunming Pharma Forms Joint Venture With Uzfarmprom State Joint Stock Company 15
Equity Offering 16
KPC Pharma Receives Approval for Private Placement of Shares 16
Kunming Pharma Plans to Raise USD203 Million in Private Placement Of Shares 17
Debt Offering 18
KPC Pharma to Raise USD48 Million in Public Offering of Bonds 18
Kunming Pharma Plans to Raise USD49 Million in Public Offering of Bonds 19
Acquisition 20
KPC Pharma Plans to Acquire 60% Stake in Dali Based Pharma Company for USD2.7 Million 20
KPC Pharma to Acquire 60% Stake in Yun’nan-Based Pharma Company for USD3 Million 21
KPC Pharma to Acquire 70% Stake in Zhejiang Holley Nanhu Pharma from Beijing Holley-Cotec Pharma for USD4 Million 22
KPC Pharma Acquires 70% Stake in Beijing Hua Fang Ketai Pharma for USD39 Million 23
KPC Pharma Plans to Acquire Chongqing based Pharma Company from Beijing based Medical Company for USD8 Million 24
KPC Pharma Plans to Acquire Beijing based Pharma Company for USD1.4 Million 25
KPC Pharma Acquires 49% Stake in Kunming-based Pharma Company from Kunming Baker Norton Pharma for USD48 Million 26
KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 27
KPC Pharmaceuticals Inc – Key Competitors 28
KPC Pharmaceuticals Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KPC Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rani Therapeutics Raises Funds in Financing 12
KPC Pharma to Form Joint Venture 14
Kunming Pharma Forms Joint Venture With Uzfarmprom State Joint Stock Company 15
KPC Pharma Receives Approval for Private Placement of Shares 16
Kunming Pharma Plans to Raise USD203 Million in Private Placement Of Shares 17
KPC Pharma to Raise USD48 Million in Public Offering of Bonds 18
Kunming Pharma Plans to Raise USD49 Million in Public Offering of Bonds 19
KPC Pharma Plans to Acquire 60% Stake in Dali Based Pharma Company for USD2.7 Million 20
KPC Pharma to Acquire 60% Stake in Yun'nan-Based Pharma Company for USD3 Million 21
KPC Pharma to Acquire 70% Stake in Zhejiang Holley Nanhu Pharma from Beijing Holley-Cotec Pharma for USD4 Million 22
KPC Pharma Acquires 70% Stake in Beijing Hua Fang Ketai Pharma for USD39 Million 23
KPC Pharma Plans to Acquire Chongqing based Pharma Company from Beijing based Medical Company for USD8 Million 24
KPC Pharma Plans to Acquire Beijing based Pharma Company for USD1.4 Million 25
KPC Pharma Acquires 49% Stake in Kunming-based Pharma Company from Kunming Baker Norton Pharma for USD48 Million 26
KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 27
KPC Pharmaceuticals Inc, Key Competitors 28
KPC Pharmaceuticals Inc, Subsidiaries 29

List of Figures
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Netmedia S.A.
    Netmedia S.A. - Strategy, SWOT and Corporate Finance Report Summary Netmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Blueberry Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a healthcare products provider that develops therapeutic products. The company develops novel therapies to treat onychomycosis. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea ped …
  • Scilex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scilex Pharmaceuticals Inc (Scilex Pharma), a subsidiary of Sorrento Therapeutics Inc is a developer of pharmaceutical products. The company develops and commercializes branded pharmaceutical products for the treatment of pain. Its technologies include drug delivery and proprietary patch tec …
  • Al Safeer Group of Companies:企業の戦略・SWOT・財務情報
    Al Safeer Group of Companies - Strategy, SWOT and Corporate Finance Report Summary Al Safeer Group of Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Honeywell Advanced Fibers and Composites:企業の戦略・SWOT・財務情報
    Honeywell Advanced Fibers and Composites - Strategy, SWOT and Corporate Finance Report Summary Honeywell Advanced Fibers and Composites - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Cytodyn Inc (CYDY):企業の財務・戦略的SWOT分析
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. Its pipeline products include Leronlimab (PRO 140), a ful …
  • KrisEnergy Holdings Ltd (SK3):企業の財務・戦略的SWOT分析
    Summary KrisEnergy Holdings Ltd (KrisEnergy) is an independent upstream company that production and development of oil and gas in the basins. The company discovers, appraises, develops and produces hydrocarbon resources. It services comprise development and production of identifying potential prospe …
  • Grupo Grana y Montero SAA (GRAMONC1):石油・ガス:M&Aディール及び事業提携情報
    Summary Grupo Grana y Montero SAA (Grana y Montero) is a group company that provides engineering and infrastructure services. The company’s business areas include engineering and construction, infrastructure development, real estate and technical services. It provides engineering procurement and con …
  • CapitaLand Limited:企業のM&A・事業提携・投資動向
    CapitaLand Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CapitaLand Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Global Marine Systems Ltd-エネルギー分野:企業M&A・提携分析
    Summary Global Marine Systems Limited (Global Marine), a subsidiary of Bridgehouse Marine Limited, is a marine technology and engineering company. It provides submarine cable installation, maintenance and engineering services. Its capabilities include project management, subsea cable installation, s …
  • Teijin Ltd (3401)-製薬・医療分野:企業M&A・提携分析
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • CMI Ltd (CMI):企業の財務・戦略的SWOT分析
    CMI Ltd (CMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Cue Health Inc:企業の製品パイプライン分析2018
    Summary Cue Health Inc (Cue Health) is a healthcare technology company that strives to design, develop, manufacture and commercialize medical diagnostic products for use in home and clinical settings. The company’s lead product, Cue Health Monitoring System, is a connected diagnostic platform that h …
  • Nissan Chemical Corporation:企業の戦略・SWOT・財務分析
    Nissan Chemical Corporation - Strategy, SWOT and Corporate Finance Report Summary Nissan Chemical Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • WS Atkins Plc:戦略・SWOT・企業財務分析
    WS Atkins Plc - Strategy, SWOT and Corporate Finance Report Summary WS Atkins Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Faron Pharmaceuticals Oy (FARN)-医療機器分野:企業M&A・提携分析
    Summary Faron Pharmaceuticals Oy (Faron Pharma) is a drug company that carries out clinical stage drug discovery and development. The company's product portfolio includes traumakine; clevegen; farbetic, an AOC3 inhibitor and D-ARDS, a diagnostic tool. Its traumakine clinical programme manages the tr …
  • Powerex Inc:企業の戦略的SWOT分析
    Powerex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cellumed Co Ltd (049180):医療機器:M&Aディール及び事業提携情報
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc is a biotechnology company that develops bone graft substitution based on human tissue graft. The company offers allograft tissue products such as bio-clearant, a clearant process that treats tissues with patented chemicals and sterili …
  • Iberia Lineas Aereas De Espana, Sa:企業の戦略・SWOT・財務分析
    Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report Summary Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose), formerly Wheelmark Plc is an investment company that offers buy, improve and sell manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipments. Its business portfo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆